Employer profile
Multiply Labs
9 open roles indexed with location, benefit, and apply-link signals where available.
Open roles
Showing the most recent indexed roles for this employer.
-
Senior Systems Integration Engineer
San Francisco
unspecified Salary not disclosedSenior Systems Integration Engineer San Francisco Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. About the Role As a Senior Systems Integration Engineer, you will be a key technical leader driving system reliability, ensuring our automated
-
Robotics Field Engineer
Los Angeles
unspecified Salary not disclosedRobotics Field Engineer Los Angeles Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. About the Role As a Robotics Field Engineer, you will be the on-site operational lead for our robotic system deployed in Los Angeles,
-
VP Software Engineering, Robotics & System
San Francisco
unspecified Salary not disclosedVP Software Engineering, Robotics & System San Francisco Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. To learn more and to view a video of our robots in action, visit us at www.multiplylabs.com and follow us
-
Open Applications at Multiply Labs
San Francisco
unspecified Salary not disclosedOpen Applications at Multiply Labs San Francisco About Multiply Labs Multiply Labs is a cutting-edge startup based in San Francisco, California, supported by top-tier tech and life science investors such as Casdin Capital, Lux Capital, and Y Combinator. Our mission is to build the best robots in the world, and use them to make the most advanced life-saving therapies accessible to all. We are revolutionizing the manufacturing of cell therapies by developing advanced robotic systems designed to automate and scale the production of these life-saving treatments. Our robots empower biopharma companies to produce cell therapies at scale without significantly changing their existing processes, reducing regulatory barriers and risks. While traditional approaches are time-consuming and lead to extremely high costs for patients (typically $1M+ per patient), using robotics can make these transformative treatments more accessible and affordable to patients in need. To learn more and to view a video of our robots in action, visit us at www.multiplylabs.com and follow us on LinkedIn . Open Applications at Multiply Labs At Multiply Labs, we're not just building robots; we're building the future of precision medicine to ensure every patient has access to life-saving therapies. This ambitious goal requires talent that is equally forward-thinking, whether you're a roboticist, engineer, or a bioprocess expert. We know that groundbreaking talent doesn't always wait for a job title. If you are relentlessly passionate about the intersection of robotics and biopharma, but don't see an open role that perfectly matches your unique expertise, we still want to
-
Executive Assistant to the CEO
San Francisco
unspecified Salary not disclosedExecutive Assistant to the CEO San Francisco About the Role Responsibilities Experience Total Rewards & Life at Multiply Labs
-
Senior / Staff Robotics Software Engineer
San Francisco
unspecified Salary not disclosedSenior / Staff Robotics Software Engineer San Francisco Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. To learn more and to view a video of our robots in action, visit us at www.multiplylabs.com and follow us
-
Scientist II
San Francisco
unspecified Salary not disclosedScientist II San Francisco Note: This role is currently part of our general interest pool. We are not actively recruiting for it at this time, but we are reviewing submissions. If a strong fit emerges and the role is prioritized, a member of our team will reach out. Thank you for your interest in Multiply Labs. Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated
-
Robotics Software Engineer II
San Francisco
unspecified Salary not disclosedRobotics Software Engineer II San Francisco Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. About the Role Responsibilities include: Qualifications Preferred Qualifications Physical & Working Conditions Travel Perks & Benefits
-
Senior / Staff Robotics Research Scientist - Dexterous & Mobile Manipulation
San Francisco
unspecified Salary not disclosedSenior / Staff Robotics Research Scientist - Dexterous & Mobile Manipulation San Francisco Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated hardware-software systems, dextrous manipulation, and imitation learning. The Location: Headquartered in San Francisco, CA. The Backing: Supported by premier investors, including Casdin Capital, Lux Capital, and Y Combinator. To learn more and to view a video of our robots in action, visit us